Drug profile · INN
metipranolol hydrochloride
OPTIPRANOLOL
metipranolol hydrochloride (OPTIPRANOLOL) is a beta-1 adrenergic receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — metipranolol hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
metipranolol hydrochloride (OPTIPRANOLOL) is a beta-1 adrenergic receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is metipranolol hydrochloride?
metipranolol hydrochloride (OPTIPRANOLOL) is a beta-1 adrenergic receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for metipranolol hydrochloride?
OPTIPRANOLOL is a marketed brand name for metipranolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metipranolol hydrochloride?
metipranolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.